Home>Blog>
TV+ x Astrazeneca

TV+ x Astrazeneca

Published: | Updated:
Simulmedia × AstraZeneca

Reach More AstraZeneca Patients Where They Watch

Your patients are watching TV. Are you reaching them?

AstraZeneca

The Challenge

Linear TV campaign in June

Ad Spend

$3,184,720.00

Missed Opportunity

68%

of target patients NOT reached

Only 32.1% reach rate = 4.8M at $658.00 per 1,000

We know your patients are watching TV.

However, they are not being reached.

15M strategic audience on TV AstraZeneca TV Viewers reached in June only 4.8M reached (32%)

Your Competition Isn't Reaching Patients Either

Dupixent also struggles with patient reach

Dupixent Campaign

Target Patient Audience Dupixent TV Viewers reached only 28% reached

72% unreached = Missed patient opportunities

Maximize Your Patient Reach with TV+

TV+ dramatically expands your reach beyond current campaigns

TV+ Optimization Solution

TV+ Maximum Reach Potential AstraZeneca Current Patient Reach June +10% more patients at the same budget

Current reach: 32.1% (4.8M at $658.00/1K)

Limited Time Offer

Ready to Reach More Patients?

See how TV+ can transform your pharma marketing with data-driven targeting and cross-channel optimization.

📊

Data-Driven Insights

🎯

Precision Targeting

💰

Budget Optimization

📺

Cross-Channel Reach

Let Simulmedia help you reach your audience

Get started with TV+ today

🔒 Your information is secure. We respect your privacy.

Data provided by Nielsen Ad Intel as of June 2025